Target intelligence / Profile preview

Zinc-dependent histone deacetylase (HDAC) (HDAC)

Target
HDAC
Molecular classification
Enzyme, Hydrolase, Histone modification, Epigenetic regulator
01

Overview

Zinc-dependent histone deacetylases (HDACs) are essential enzymes that regulate gene expression by removing acetyl groups from lysine residues on histone tails and various non-histone proteins (UniProt, 2023). This enzymatic activity is mediated by a catalytic zinc ion (Zn2+) coordinated within a deep hydrophobic pocket, which facilitates the hydrolysis of the amide bond in acetylated lysines (Seto & Yoshida, 2014). By promoting chromatin condensation, HDACs typically act as transcriptional repressors and are vital for maintaining cellular homeostasis, including cell cycle progression and apoptosis (Ho et al., 2020). In many cancers, HDACs are overexpressed or dysregulated, leading to the silencing of tumor suppressor genes and promoting oncogenesis (Falkenberg & Johnstone, 2014). Therapeutic intervention focuses on small-molecule inhibitors that contain a zinc-binding group, such as a hydroxamate or benzamide, which chelates the active-site zinc to block substrate access and restore normal acetylation levels (PubMed, 2020).

Other names
Histone deacetylaseLysine deacetylaseKDACZinc-dependent HDAC active siteHDAC zinc coordination pocket
02

Mechanism of action

Inhibition of enzymatic activity through chelation of the catalytic zinc ion within the active site, preventing the deacetylation of lysine residues on histones and non-histone proteins.

03

Biological functions

Gene expression regulationChromatin remodelingCell cycle regulationApoptosisProtein deacetylation
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseHematological malignancy
05

Safety considerations

ThrombocytopeniaNeutropeniaQT interval prolongationGastrointestinal toxicityFatigue
06

Interacting drugs

Vorinostat

5 more in the full profile.

07

Biomarkers

Histone H3 acetylation levelsHistone H4 acetylation levelsp21 (WAF1/CIP1) expressionHR23B protein levels (for cutaneous T-cell lymphoma)

Beyond the preview

Go deeper on Zinc-dependent histone deacetylase (HDAC) (HDAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-dependent histone deacetylase (HDAC) (HDAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call